SK Chemical to agree exclusive distribution of TMX-67.

Published: 2004-08-06 06:56:00

Updated: 2004-08-06 06:56:00

SK Chemical and SK pharmaceutical division made a technical licence agreement with Japanese Deijin on July 13 for an exclusive distribution of TMX-67 (febuxostat) in Korea, a new compound for the treatment of gout, the health registration of which is still underway in Japan.

TMX-67 is an orally administered Xanthine oxidase inhibitor anti-gout drug, the mode of action of which is absolutely...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.